Paper Details

  1. Home
  2. Paper Details

Evaluation of the efficacy and safety of guanabenz versus clonidine.

Author: AsmalA C, LearyW P, WilliamsP C

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Controlled Clinical TrialA clinical trial that evaluates the effectiveness of a treatment by comparing a group that receives the intervention with a group that receives a placebo or standard treatment.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

Guanabenz and clonidine were both effective in reducing blood pressure in patients with uncomplicated essential hypertension. Both drugs had similar side effects, such as dry mouth and drowsiness.
Paper Details　
Original Abstract of the Article :
The antihypertensive efficacy and safety of guanabenz were evaluated against clonidine in two groups of 18 patients with uncomplicated essential hypertension. Both compounds reduced systolic and diastolic blood pressure at the doses used, whether pressures were measured in the supine or standing pos...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/371036

データ提供：米国国立医学図書館（NLM）

Guanabenz vs. Clonidine: A Race Through the Desert of Hypertension

Hypertension, a common and potentially serious health condition, has long challenged researchers seeking effective and safe treatment options. This study delves into the comparative efficacy and safety of two antihypertensive drugs, guanabenz and clonidine. The authors present a head-to-head comparison of these two drugs, demonstrating their effectiveness in reducing blood pressure while highlighting similar side effect profiles. This research provides valuable insights into the treatment landscape for hypertension, offering guidance for clinicians seeking the most appropriate treatment options for their patients.

A Close Race: Guanabenz vs. Clonidine

The authors' findings demonstrate that both guanabenz and clonidine effectively reduce blood pressure, offering valuable treatment options for patients with hypertension. This research highlights the importance of a comprehensive understanding of various antihypertensive medications, allowing clinicians to tailor treatment strategies to meet the unique needs of each patient. The study also underscores the importance of considering potential side effects when selecting medications, ensuring that the benefits of treatment outweigh any potential risks.

Navigating the Desert of Treatment Options

This research provides valuable insights into the treatment of hypertension, highlighting the effectiveness of both guanabenz and clonidine. The authors' findings emphasize the importance of a comprehensive understanding of various antihypertensive medications, allowing clinicians to make informed decisions regarding the most appropriate treatment options for their patients. This study serves as a roadmap for navigating the vast and often complex desert of treatment options, ensuring that patients receive the most effective and personalized care.

Dr.Camel's Conclusion

This study sheds light on the effectiveness and safety of both guanabenz and clonidine, two valuable tools in the fight against hypertension. Like a traveler navigating a vast and challenging desert, researchers have unearthed two promising paths to lower blood pressure. The authors' findings underscore the importance of a comprehensive understanding of various antihypertensive medications, allowing clinicians to make informed decisions and provide the best possible care for their patients.

Date :
  1. Date Completed 1979-05-26
  2. Date Revised 2014-09-12
Further Info :

Pubmed ID

371036

DOI: Digital Object Identifier

371036

Related Literature

Article Analysis
・Side Effects of guanabenz
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.